Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Lucid Diagnostics Inc. Director's Dealing 2025

Feb 21, 2025

33983_dirs_2025-02-21_e45d8d5f-b7cc-4379-855d-391ebe1174aa.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lucid Diagnostics Inc. (LUCD)
CIK: 0001799011
Period of Report: 2025-02-20

Reporting Person: Matheis Dennis (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-02-20 Common Stock A 112800 Acquired 162725 Direct

Footnotes

F1: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2028. Such restricted stock is subject to forfeiture if the requisite service period is not completed